Pictet Asset Management
LAB icon

Pictet Asset Management’s Standard BioTools LAB Stock Holding History

Pictet Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Hold
11,366
– – ﹤0.01% 2102
2025
Q4 		$14.5K Hold
11,366
– – ﹤0.01% 2081
2025
Q3 		$14.8K Hold
11,366
– – ﹤0.01% 2031
2025
Q2 		$13.6K Hold
11,366
– – ﹤0.01% 2000
2025
Q1 		$12.3K Hold
11,366
– – ﹤0.01% 2009
2024
Q4 		$19.9K Hold
11,366
– – ﹤0.01% 2041
2024
Q3 		$21.9K Hold
11,366
– – ﹤0.01% 2016
2024
Q2 		$20.1K Hold
11,366
– – ﹤0.01% 1969
2024
Q1 		$30.8K Buy
+11,366
New +$27.4K ﹤0.01% 1961

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Pictet Asset Management's LAB Position: Q1 2026 in Review

Pictet Asset Management held its Standard BioTools (LAB) position steady in Q1 2026 at 11,366 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Pictet Asset Management first reported a position in LAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $30.8K in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Pictet Asset Management held 11,366 shares of Standard BioTools worth $10.4K as of Q1 2026.
  • Pictet Asset Management left its Standard BioTools share count unchanged in Q1 2026.
  • Standard BioTools made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #2102 holding.
  • Pictet Asset Management first reported a position in Standard BioTools in Q1 2024 and has held it in 9 quarters since.
  • Pictet Asset Management's Standard BioTools position peaked at $30.8K in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.